Full Breakdown
Tailored Cancer Screening Strategies for People with HIV
10/29/2025, 10:54:43 AM
Overview of the Need for Tailored Screening
Recent studies presented at the 20th European AIDS Conference (EACS 2025) in Paris emphasize the urgent need for customized cancer screening strategies for individuals living with HIV. Research indicates that prostate cancer is diagnosed at a younger age and is often more advanced in men with HIV. Additionally, women with a lower nadir CD4 count face increased risks for anal and cervical cancers. Despite the heightened risk, many individuals do not receive appropriate screenings, particularly for liver cancer, where those without cirrhosis often remain unscreened.
Prostate Cancer Screening Insights
Prostate cancer is the most frequently diagnosed cancer among men in Europe. A review of diagnosis patterns revealed significant variations in screening practices across countries, largely influenced by the use of prostate-specific antigen (PSA) testing. A study involving 161 men with HIV from 16 clinics in Germany found that the median age at diagnosis was 61, significantly younger than the general population's median of 71. Notably, 26% of these cases had already metastasized at diagnosis, with a higher likelihood of advanced cancer in men with CD4 counts below 500. The German researchers recommend initiating PSA screening at age 45 for men with HIV, aligning with national guidelines.
Anal Cancer Screening Challenges
International guidelines suggest that women with HIV over 45 should undergo anal cancer screening. However, a study at Padua University Hospital in Italy found that nearly 45% of women declined screening, often citing a lack of perceived risk. Women who had been vaccinated against high-risk HPV or had a history of HPV-related diseases were more likely to accept screening. Among those screened, 5.9% were diagnosed with anal cancer, highlighting the need for increased awareness and education regarding anal cancer risks.
Cervical Cancer Screening Disparities
Women with HIV are also at a higher risk for cervical pre-cancer and cancer. A study conducted in the Netherlands from 2000 to 2023 found that 2764 women underwent cervical screening, resulting in 246 cases of high-grade cervical intraepithelial neoplasia (CIN2+) and 121 cases of CIN3+. Factors such as lower nadir CD4 counts and shorter periods of viral suppression were associated with higher rates of these diagnoses. Researchers advocate for prioritizing younger women and those with low CD4 counts for cervical screening.
Liver Cancer Screening Gaps
Individuals with HIV and hepatitis are at an elevated risk for hepatocellular carcinoma (HCC). Despite EACS recommendations for biannual HCC screening in high-risk populations, a study across 48 centers in Spain, Germany, and Poland revealed that only 28% of eligible individuals had been screened. Screening rates were notably lower among those without cirrhosis, underscoring the need for improved adherence to screening guidelines.
Conclusion and Recommendations
The findings from these studies underscore the necessity for tailored cancer screening protocols for people living with HIV. Enhanced education and awareness campaigns are crucial to ensure that at-risk populations understand their vulnerabilities and the importance of regular screenings. By implementing targeted strategies, healthcare providers can improve early detection and outcomes for individuals with HIV.
